English
Polski
Español
українська
New trends in the management of thromboembolism
What are some of the new trends in the management of thromboembolism?
2018-10-22
What are some of the new trends in the management of thromboembolism?
What anticoagulation treatment should be used in a patient with active cancer and atrial fibrillation after deep vein thrombosis (DVT)?
In what patients treated with vitamin K antagonists should we use perioperative bridging therapy?
In what patients should antithrombotic treatment be continued despite surgery or invasive procedures?
If no thrombus is seen in the popliteal vein on ultrasonography one month after the event, is it possible it may have travelled to the pulmonary artery?
A 40-year-old otherwise healthy man had a popliteal vein thrombosis after a 9-hour flight. One month after the event there was no sign of a thrombus on ultrasonography and D-dimer levels were normal. What prophylaxis should be used in this patient before long-haul flights in the future?
How can we balance the risk of recurrent venous thromboembolism following an episode of unprovoked VTE and the increased bleeding risk associated with continued anticoagulation?
What should be the anticoagulation treatment in a patient receiving long-term vitamin K antagonists or novel oral anticoagulants in whom an interventional procedure is planned? Is it necessary to discontinue the anticoagulants, or is it safe to perform the procedures while the patient is on therapeutic doses of the anticoagulant?
What is your opinion on using bridging therapy in patients with a history of deep vein thrombosis?
What are the 2017 recommendations on the use of bridging therapy – should it be routinely used or not?
